Benefits of Hyperbaric Oxygen Therapy for Individuals with a Cancer Diagnosis

 Dr. Jess Sabrowsky DNP, RN, FNP-BC

Do you know someone undergoing treatment for cancer? You might be asking what you can do to help. It is known that the brain and tissues in the body are affected when oxygen saturation levels dip below 90% because oxygen is not getting to the cells or brain. Now you ask, what is the purpose of Hyperbaric Oxygen Therapy (HBOT)? HBOT involves breathing pure oxygen in a pressurized environment helps the lungs collect and circulate more oxygen throughout the body offering countless health benefits: improving brain fog, helps wounds and damaged tissues by supporting the body to build new blood vessels, eliminate toxins and prevent infections. While it is not a cure for cancer, HBOT can serve as a complementary therapy that enhances the overall treatment experience and supports healing in various ways. Coupled with Pulse Electromagnetic Field Therapy (PEMF), HBOT can “supercharge” the body, optimizing cellular function and promoting overall health. Here is a summary of the key benefits of HBOT:

1. Enhanced Oxygen Delivery: Cancer cells thrive in low-oxygen environments, and HBOT increases oxygen levels in the body. This enhanced oxygen delivery can improve the effectiveness of certain cancer treatments, such as radiation therapy and chemotherapy. By providing a higher concentration of oxygen, HBOT can make cancer cells more sensitive to these treatments, potentially leading to better outcomes.

2. Improved Wound Healing: Individuals undergoing cancer treatments often experience delayed healing, particularly after surgeries or radiation therapy. HBOT promotes the formation of new blood vessels (angiogenesis) and enhances collagen formation, which can accelerate wound healing. Improved healing can lead to fewer complications and a better quality of life for patients.

3. Reduction of Radiation Side Effects: Radiation therapy can cause side effects, including tissue damage and radiation burns. HBOT has been shown to mitigate some of these adverse effects by promoting tissue repair and reducing inflammation. Patients receiving HBOT prior to and in conjunction with radiation therapy may experience less pain and faster recovery times.

4. Decreased Inflammation: Chronic inflammation is associated with cancer progression and treatment side effects. HBOT has anti-inflammatory properties, which can help reduce swelling and discomfort in patients. By decreasing inflammation, HBOT may improve overall comfort and enhance the patient’s ability to tolerate other treatments.

5. Immune System Support: HBOT can stimulate the immune system, enhancing its ability to fight infections and disease. For cancer patients, a robust immune response is crucial, especially as treatments like chemotherapy can weaken immune function. By supporting immune health, HBOT may help reduce the risk of infections, leading to better overall health during treatment.

6. Pain Relief: Many cancer patients experience chronic pain as a result of their illness or treatment side effects. HBOT has been reported to alleviate pain by promoting healing and reducing inflammation. Patients may find relief from pain, making it easier to engage in daily activities and maintain a positive outlook.

7. Psychological Benefits: Cancer can take a significant toll on mental health, leading to anxiety and depression. The experience of undergoing HBOT can provide patients with a sense of control over their treatment and a proactive approach to their health. Additionally, the therapeutic environment of the hyperbaric chamber may foster relaxation and stress relief, contributing to improved mental well-being.

8. Enhanced Quality of Life: By addressing various side effects and complications associated with cancer and its treatments, HBOT can significantly improve the quality of life for patients. From reducing pain and inflammation to speeding up recovery and enhancing overall health, the holistic benefits of HBOT can empower patients to better manage their condition and maintain an active lifestyle.

9. Overall, Health Optimization with PEMF: When combined with Pulse Electromagnetic Field Therapy (PEMF), HBOT can further enhance overall health by optimizing cellular function. PEMF therapy promotes cellular regeneration, improves brain health, and aids in recovery by enhancing blood circulation and reducing pain. Together, HBOT and PEMF allow the body to prepare for surgery, accelerate post-operative healing, and reduce complications. This powerful combination can lead to improved mental clarity, energy levels, and overall well-being.

10. Potential for Combination Therapy

HBOT can be integrated into a comprehensive treatment plan alongside conventional cancer therapies. This combination approach may enhance the efficacy of treatments, improve patient outcomes, and provide a more supportive environment for healing. Patients should consult with their oncologist to determine how HBOT can fit into their overall care plan.

Conclusion: While hyperbaric oxygen therapy is not a standalone treatment for cancer, its benefits can significantly enhance the overall treatment experience for individuals with a diagnosis of cancer. From improving oxygen delivery and promoting wound healing to reducing inflammation and supporting immune function, HBOT offers a range of advantages that can lead to better health outcomes. When paired with PEMF therapy, patients can achieve even greater health optimization at the cellular level, “super-charging the body” improving brain health and expediting recovery. Patients considering HBOT should consult their healthcare providers to explore its potential as part of a comprehensive cancer treatment strategy. By embracing innovative therapies like HBOT and PEMF, individuals with cancer can take proactive steps towards improving their health and well-being during their cancer journey and beyond.

Northport Wellness Center Alliance Member, Dr. Jess Sabrowsky founded direct primary care (DPC) practice, Dr. Jess Empowered Health & Wellness, to improve the lives of individuals. She delivers exceptional integrative functional family wellness care, while offering unique health prevention assessments focused on promoting overall wellness and improving longevity. Dr. Jess believes the relationship between the provider and client helps build optimal health. Dr. Jess takes extraordinary pride in ensuring her clients’ experience is second to none. When a client signs up to be a member of Dr. Jess Empowered Health & Wellness, they have the opportunity to build a relationship with a trusted team dedicated to offer empowered, non-judgmental healthcare.

---

A PARADIGM SHIFT IN WOUND CARE

Dr. Jose L. Ramirez-GarciaLuna
Polymedics Innovations (https://polymedics.com/) is a German company based in Stuttgart and is the leading medical device company specializing in synthetic skin substitutes for wound and burn care. Their flagship products, Suprathel and Supra SDRM, are designed to promote better and more rapid wound healing and improve patient outcomes in challenging clinical scenarios. These polymeric synthetic skin substitutes provide a controlled environment conducive to tissue regeneration and minimize the risks associated with traditional biological grafts. The products are composed 75% of poly-lactic acid, which is a safe biological material approved by the FDA since the '50s and widely used in sutures, implantable devices and prosthetic joints, and 25% other FDA-approved structural polymers. (see complete article)

HEALTHTECH REPORT: REGULATION THERMOGRAPHY/THE ALFASIGHT 9000
Our associate editor and HealthTech product user Dr. Leslie Valle-Montoya endorses this device for its remarkable feture design to detect the organ dysfunctions. In August of 2024, HealthTech Reporter conducted a private interview with Dr. Daniel Beilin (CTO & Founder) about establishing the science of Regulation Thermography and his ALFA System. According to their marketing, the AlfaSight 9000™ (also known as the ALFA‐Scan System) is a robust, easy‐to use, and reproducible measurement system that utilizes streamlined infrared technology, artificial intelligence (AI) ‐ and years of world‐corroborated, accumulated data. It’s a whole‐body, early‐detection system that views a patient’s overall health while finding hidden issues and causes for many disease including pre‐disease contributing factors. (See full story@ HTR News)

---

Sponsored Advertisers:

Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

HealthTech Mentorship Journal: What is a PAPIMI?

By: Leslie Valle-Montoya 

I recently returned from an enriching 8-day seminar in Schwellbrunn, Switzerland, held by Swiss Biological Medicine expert, Dr. Thomas Rau (L). This international seminar brought together 30 colleagues from 11 countries, with half the attendees being Biological Dentists, creating a vibrant, interdisciplinary learning environment.

The seminar covered a comprehensive range of techniques and insights into Bioenergetic treatments, identifying Root Causes of illness, IV infusions, Biological Dentistry, and Darkfield microscopy. One of the highlights was my introduction to a new device, the PAPIMI PEMF (R), which is unlike typical PEMF devices due to its use of low Tesla and high induction technology. This ion induction therapy works on the cell membrane potential for optimal cell metabolism.  I’m excited to bring this innovative tool into my practice in the coming year, as I deepen my approach to addressing root causes in patient care.

A healthy cell needs sufficient cell membrane voltage (approximately -70mV to -90mV) to maintain its regulatory processes. All illnesses and injuries have one thing in common: cells begin to lose cell membrane potential (energy). This is why I include pulsed electromagnetic field therapy for all my patients, as it enables the cell to resume regulatory processes, exchange trace elements, and produce essential energy molecules.

One crucial point we addressed in healing was the significance of silent infections in the dental field. I am trained to assess and address dental health as it can be a root cause of illness and dysregulation. This is critical! Among my colleagues in Biological Medicine, we found that over 90% of breast cancer patients—and many other cancer diagnoses—have either dental toxicity or old root canals as part of the "root cause" of illness, often without any dental symptoms. As long as dental disturbances are not resolved, the risk of cancer recurrence is significantly higher.

I wanted to share a few topics and techniques I was exposed to while on my trip to Switzerland as I truly believe this is true medicine.  Finding the root cause rather than merely chasing symptoms is essential, as is the importance of preventative medicine; much inflammation can be asymptomatic for years before a diagnosis is received. 

(L) View of live blood under Darkfield Microscopy, a technique to enhance contrast in specimens that are not imaged well under normal illumination processes. Live blood drop is analyzed using a high-resolution microscope to study the present state of our cells.

Dental plaque of a cancer patient under Darkfield Microscopy - A study of persons oral “milieu” to analyze relevant signs of silent inflammation, microbiome dysfunction and what components are present in dental plaque of a patient with breast cancer. 

  

*Neural therapy is the treatment of pain and other illnesses by finding and treating disturbances in the body’s electrical system. These disturbances are called interference fields, which are a result of autonomic nervous system responses. Neural therapy involves the injection of a local anesthetic mixed with other ingredients into the interference fields. The theory behind neural therapy is that trauma can cause long-term disruption of the electrochemical function of cells and tissue, resulting in dysfunction, and the goals are to correct the interference and facilitate healing.

 

Heart Rate Variability

VIDEO BANK

Dr. Jess/Hyperbaric

Prof: Langer

Dr. Berka on Recurrence

Photobiomodulation and Skin Cancer: Summary of Current Evidence

INTRODUCTION- The Integrative Health Research Center/IHRC in NYC conducted a 2-year performance study in the use of various LED-based near-infrared light health devices.  The test was aptly named "Scan & Treat" whereby each model was tested on consenting subjects (as directed by its accompanying instructions and training programs). Brands ranged in frequency and design supporting various health claims.  All devices under review presented documentation and instructions based on each manufacturer's standard testing policies as approved by regulatory agencies for public market.

As part of any device research protocol, standard interest for user safety led to this micro-inquiry/survey of these devices, exploring the probability of injury and risk.  This, our evaluators seek any form of published evidence about the risks in applying radiative energy frequency and laser directly exposed to the skin within any close proximity.  Though designed for supposed therapeutic results, our challengers wish to explore any research concluding probable cause for concern or any form of negative effect.

Additional concern is PBMT's effects on cancers, especially skin cancers and melanoma where direct exposure of this 'light therapy' on an infected area may awaken or aggravate the cancer's  malignancy. Where PBMT is identified on the market (and with the brand's marketing claims) to reduce inflammation, an adverse concern is for the potential unknowns of a tumor's aggressiveness to be provoked by the device's exposure.

The following are statements and findings from a 2nd and 3rd level academic data search.  All references and expanded details are accessible by the links enclosed.

SAFETY INQUIRY/REVIEW (10-19-2024)
An academic research/report by:
Dr. Roberta Kline - editor, HealthTech Reporter / Women's Health Digest

Photobiomodulation therapy (PBMT) is the currently accepted term for the use of near (visible) or near infrared light to stimulate physiological processes in biological tissues. It is also often called low-level laser therapy (LLLT), which was introduced in the 1960’s. [De Pauli Paglioni, et al]

LED (Light Emitting Diode) is often included in PBMT and while around since the late 1920’s it is only since the late 1960’s that it has been used therapeutically. Its use is increasing in therapeutic applications as it is less expensive than laser. [De Pauli Paglioni, et al]

They both operate within defined spectrums of light, with visible red being 600-700 nm and near-infrared (NIR) being 700-1400nm. These wavelengths correspond to the maximal absorption of skin without creating heat.  [Torres, Angeli E et al.]

While there are differences between LLLT and LED, they have been found to be equally effective in many use cases, including wound healing, inflammation, and pain relief. [Torres, Angeli E et al.]

Table 1 source: Torres, Angeli E et al.

THE CRITICAL ROLE OF DIAGNOSTICS IN HEALTH AND WELLNESS  By: Dr. Jess Sabrowsky DNP, RN, FNP-BC What I have learned over the years is the importance of listening to the patient, but equally, the importance of using data-driven diagnostics to make real-time decisions about care. This is not just about numbers on a chart—it is about understanding the full picture of your health, long before symptoms arise. We need to use technology, diagnostics, and assessment techniques to gather real data. Data that can guide each patient on their unique health journey. Diagnostics help us understand the true state of a person’s health, even when they may not feel “sick.” This is where the rubber meets the road: when you find a PCP who truly understands the importance of these tools and works with you to achieve your wellness goals and who also has skills beyond the transitional medical model to help you live your best life. Having difficult conversations is uncomfortable, but it is necessary for growth. If you want a healthcare provider who will partner with you—someone who creates a safe space, builds trust, and encourages honest dialogue to support long-term growth—then you must also be willing to put in the effort. Finding a provider who matches your commitment to your health, and one who uses diagnostics to empower you, is key to achieving your goals. WHY DIAGNOSTICS MATTER In short, diagnostics are essential because they offer concrete, actionable insights into your health that go beyond surface-level symptoms. They help uncover hidden health risks and enable early intervention, which can be the difference between preventing a chronic condition or managing it effectively. Diagnostics allow for personalized care tailoring interventions to meet the specific needs of the individual based on real, measurable data. I also would add that as a provider I prefer to reference functional lab ranges when reviewing results as I find that I can make small preventative recommendations and also challenge individuals and providers to think outside the box when looking to help resolve health conditions, like in the case of my daughter who otherwise would still be suffering. Let’s aim to stop the suffering and optimize wellness for all who seek it.

MECHANISM OF ACTION
PBMT works via absorption by mitochondrial chromophores including Cytochrome c oxidase and flavoenzymes, which facilitate electron transport and ATP synthesis. It also is involved in release of nitric oxide (NO) which is involved in mitochondrial antioxidant defense and would account for clinical and research observations that PBMT helps to mitigate oxidative damage from radiation or chemotherapy. Gene expression influenced to enhance regeneration and repair, including cell proliferation & migration, immune and angiogenesis. [Glass GE.]

Cells with higher concentrations of mitochondria appear to require lower doses for therapeutic effects, whereas cells such as fibroblasts and keratinocytes require more due to lower mitochondrial density. [Glass GE]

PBMT AND CANCER
Multiple cell culture and animal studies have shown that PBMT has little or no effect on cancer cell viability, nor does it induce neoplastic changes in normal cells. The rare studies that showed a possible effect were in animals with compromised immune systems. [Glass GE]

A large review published by Bensadoun RJ et al in 2020 showed that animal studies and clinical trials support the safety of PBMT related to tumor growth, and may even be beneficial for overall survival in patients with cancer. The conflicting results from a few in vitro cell culture studies were felt to be related to doses outside of normal clinical use, and thus not relevant to safety in humans.

In 2022, a position paper from the WALT Congress [Robijns J et al.] stated that PBMT has been shown to have a biphasic dose-response, with lower doses having potentially less effect and higher doses having potentially no beneficial or even adverse effects, that warrants further clinical research to clarity optimal dosage.

They also stated that the genetic variability of individual tumors, as revealed by the technology of precision oncology, may contribute to variable response to PBMT. Indeed, some tumors have genetic variations in genes that are targeted by PBMT, such as PI3K. One example is squamous cell cancers of the mouth, where up to 35% of tumors have alterations in the PI3K pathway. Thus, further research with this more individualized approach is needed and should replace one-size-fits-all approaches.

Their conclusion was that, although PBMT is generally safe for patients with cancer, there is a lack of definitive evidence regarding potential enhancement of tumor growth and long-term survival, thus more clinical trials and robust data regarding use with cancer are needed. They also specifically did not recommend direct treatments to the tumor, and advised that all patients should be fully informed of the potential benefits and risks.

 

References:

1) Glass GE. Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation. Aesthet Surg J. 2023 Apr 10;43(5):NP357-NP371. doi: 10.1093/asj/sjad018.

2) De Pauli Paglioni, Mariana, et al. "Tumor Safety and Side Effects of Photobiomodulation Therapy Used for Prevention and Management of Cancer Treatment Toxicities. A Systematic Review." Oral Oncology, vol. 93, 2019, pp. 21-28, https://doi.org/10.1016/j.oraloncology.2019.04.004.

3) Torres, Angeli E., and Henry W. Lim. "Photobiomodulation for the Management of Hair Loss." Photodermatology, Photoimmunology & Photomedicine, vol. 37, no. 2, 2021, pp. 91-98, https://doi.org/10.1111/phpp.12649.

4) Bensadoun RJ, Epstein JB, Nair RG, et al. World Association for Laser Therapy (WALT). Safety and efficacy of photobiomodulation therapy in oncology: A systematic review. Cancer Med. 2020 Nov;9(22):8279-8300. doi: 10.1002/cam4.3582.

5) Robijns, Jolien, et al. "Photobiomodulation Therapy in Management of Cancer Therapy-induced Side Effects: WALT Position Paper 2022." Frontiers in Oncology, vol. 12, 2022, p. 927685, https://doi.org/10.3389/fonc.2022.927685

Dr. Yvette Groszmann, OB/GYN - What is Sonology? (Ultrasound Imaging)

HealthTech Reporter is proud to present our next expert in the field of imaging. YVETTE S. GROSZMANN, MD, MPH, completed a residency in Obstetrics and Gynecology at Pennsylvania Hospital, Philadelphia. In 2009, she left general ob-gyn practice to pursue a fellowship in ob-gyn diagnostic ultrasound with Dr Benacerraf and is now an expert sonologist in early pregnancy and gynecologic ultrasound. She is a fellow of the American College of Obstetrics and Gynecology, a Fellow of the American Institute of Ultrasound (AIUM), former vice president of the American Institute of Ultrasound (AIUM), Chair of the AIUM Gynecology Community of Practice, and a lecturer at Harvard Medical School. She teaches gynecologic ultrasound to the Brigham and Women’s ob-gyn residents and REI fellows, has co-authored a textbook on gynecologic ultrasound, and lectures nationally and internationally.

 

In a recent interview, Dr. Groszmann shares her vision for improved patient care through the philosophy of direct contact with the patient and ultrasound probe. The concept of investigating and recognizing pathology is more efficiently captured by the physician and she discusses this in an excerpt from HTR newscast.

INTERVIEW TRANSCRIPT from Podcast (AIUM Speaker Series)- 5/2024
I became a Gynecologic Sonologist because two of the other physicians in my group were maternal fetal medicine doctors who also did gynecologic ultrasound, but they were more interested in the fetuses.  I frankly, was more interested in the pelvis. I transitioned over the years and I became a specialist in GYN ultrasound. I co-wrote a textbook on this topic. Maybe half of our practice is second opinions, especially in GYN ultrasound. Ultrasound is not typically performed by the physician. It's performed by sonographers (ultrasound technicians). They're taught very well but there is an added layer of validity when you, the physician is the one taking the images, when you understand the physiology and what you're looking at-- it affects interpretation. Our sonographers are excellent-   there's so much more control in scanning the patient if YOU the physician are the one navigating the probe firsthand.

 

---

Cohort Study (Part 1)- Dense Breast Scanning Survey / Molloy University: 

ACADEMIC PREFLIGHT STUDY OF ULTRASOUND SCREENING APPLICATIONS FOR DENSE BREAST CASES

Transcript by: Noelle Cutter, Ph.D.

Edited by: Roberta Kline, MD and Lennard M. Goetze, Ed.D

We started working with the Terason 3200t Ultrasound (hereinafter shall be referred to as the Terason) in the summer of 2022. The goal of the project was to be able to scan a limited number of younger premenopausal women under the age of 40 who are more likely to have dense breasts based on their status as being endurance based athletes. We have been exclusively using the Terason based on the recommendation of our lead radiologist Dr. Robert Bard.  The Terason became our lab scanner of choice to conduct the screening of 10 individuals in the lab on a voluntary basis to get a readout for their breast density. Endurance athletes are more prone to dense breast tissue, especially athletes under the age of 40. Mammographic density is the strongest risk factor for non-familial breast cancer among women, especially those under the age of 40.   Metastasis, tumor relapse, and resistance to therapy remain the principal causes of death for breast cancer patients and the lack of effective therapies calls for an improved understanding of the molecular mechanisms driving breast cancer progression. Early identification of mammographic density is an essential step in preventative health.

*** See Dr. Noelle Cutter's Overview on this Phase 1 Study of Dense Breast Survey

REMOTE COLLABORATIVE TEAM

The Dense Breast paradigm continues to plague our population of the underdiagnosed and underserved women. uniting with public advocates and legislative change makers like the ARE YOU DENSE? FOUNDATION raises significant public awareness in both the clinical and patient communities (see news feature).  Meanwhile, this cohort study received great support from the medical research and diagnostic society whereby scientific leaders like Dr. Robert L. Bard (diagnostic imaging specialist) and Dr. Roberta Kline (epigenetics expert in women's health) helped to spearhead their own respective areas of study to help offer new insight and data in support of the launch of this field research program.  

PORTABLE, HOSPITAL GRADE AND FIELD FRIENDLY

My technicians and I found the Terason to be "super portable" and upon scanning our first few subjects, we immediately understood why Dr. Bard suggested this brand and model. The picture quality and imaging system is very clear and the user interface is very easy to read. For someone who is not experienced or well trained in using an ultrasound, with one or two training sessions I was able to easily use the machine to work with our volunteer subjects. 

An underlying test is the feasibility of using the Terason itself in actual field work. The portability is astounding (to me). This means we can pack it up. I don't even need any sort of a car. I could throw it on my back and get on a bicycle and bring it to a, uh, a destination.  

Click image to see full scan report

As far as its' performance, my group and I did our own homework about its accuracy and reliability and what we often found was the common statement about it being "battle-tested"- in the EMS world). Targeting the triathlete community, all these features are critical advantages to roadside screening! It's easy to use and even easier to train other research assistants in the lab to use it. And with Dr. Bard (and his expert interpretation) on the receiving end of our scans, that is the ultimate peace of mind and a COMPLETE tele-health scanning paradigm. 

FINAL STATEMENT
Breast density is a key factor in early detection because mammograms routinely miss breast cancer in dense breasts, especially in younger and more athletic women. Ultrasound offers a supplemental scan and peace of mind because it finds the pathology and almost instantaneously distinguishes from a benign cyst from a possible cancer - or a definite cancer. Ultrasound even goes further because if there is a definite cancer or something highly suspicious of a cancer, you can look at the other organs such as the glands under the arm to see if it's spread into the lining of the lungs to see if it's invading the pleura or the lymph nodes in the abdomen or the brain. Since we are now armed with expert diagnostic over-readers and remote collaborative imaging options, I urge our gynecologic and obstetric community to take advantage of this affordable non-invasive screening solution. 

DR. NOELLE CUTTER is a professor of biology, ironman finisher, and advocate for dense breast screening.  United with an expanding research team dedicated to collecting data on women with dense breasts and screening options for these patients, her initiative aims to investigate and gather conclusive information about dense breasts in specific groups- including age, body mass index, and amount of physical activity and the underlying diagnostics of breast cancer tumors. This research program is under a partnership with Molloy College and Dr. Robert Bard, expert diagnostic cancer imaging specialist in NYC and other colleagues from the NY Cancer Resource Alliance. 

 

---

Epigenetic Research Notes: Profiling the Dense Breast Paradigm

A Clinical Report by: Dr. Roberta Kline

LINKING DENSE BREAST WITH BREAST CANCER

We have known for a very long time that there is an increased risk of breast cancer for women who have dense breasts. Until recently, the research has been lagging in terms of what's the molecular mechanism, why do dense breasts present an increased risk of breast cancer? Without this knowledge, we can’t address the root causes, and are left with a lot of trial and error based on incomplete understanding. 

It's very encouraging to know that currently there are 124 clinical trials ongoing looking at dense breasts and the relationship with breast cancer, anywhere from improved diagnostics, to treatment, to prevention, and, what’s close to my heart, to understanding the molecular mechanisms - what's happening at the cell level, at the genetic level that is causing different women to have an elevated risk of breast cancer.  One of the striking features that we're learning about dense breasts and what is creating that density is the microenvironment, which means the environment in the supporting tissue surrounding the glands. This includes fibroblasts and collagen. It seems that rather than estrogen being the dominant factor, it is inflammation that is creating the increased density of breast tissue. 

(See full report @ PINKSMARTNEWS)

 

---

WHAT'S NEXT AFTER CANCER?

The Importance of Maintaining a Healthy Lifestyle and Monitoring

Written by: Dr. Leslie Valle-Montoya 

Cancer recurrence can occur months or even years after initial treatment, and it’s important to be aware that cancer can return in different tissues, not just where it was originally diagnosed. While this is a challenging possibility, there are proactive steps you can take to reduce the risk and protect your health.

Staying vigilant with regular check-ups, lifestyle adjustments, and continued screenings is essential. Early detection of any signs of recurrence greatly increases the chances of successful treatment. Maintaining a healthy lifestyle after being declared “cancer-free” is not always easy, but it’s vital. We are constantly exposed to environmental toxins in our food, water, and surroundings, so addressing the root causes of disease and making healthier choices is crucial. A nutritious diet, physical activity, and stress management all support overall wellness and strengthen the immune system. I often guide patients in addressing lingering dental infections and maintaining a healthy internal environment, whether by enhancing the microbiome or reducing bodily acidity, which cancer thrives on.

Avoiding smoking, limiting alcohol, and maintaining a healthy weight are also key to lowering the risk of recurrence. By focusing on what you can control—your health and regular monitoring—you empower yourself to stay well and ensure long-term health.

WOMEN’S HEALTH COLLABORATIVE GOES TO ALBANY

May 21, 2024, leading members of the NY Cancer Resource Alliance (NYCRA) held a special meeting with State Senator Patricia Canzoneri‐Fitzpa...

27 Year Old Stage 3 Breast Cancer Victim Survived - Despite of Docs Who MISDIAGNOSED!   The Women's Health Collaborative and EARLIER DETECTION advocate Alexandra Fiederlein interviewed breast cancer survivor Jamie Butera a...

 

---

Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

Rough Cut: Prof. Robert Langer